Clinical Trial Update: A Safety and Efficacy Study of Tralokinumab in Adults With Asthma [Phase 2]

View source ↗

Summary

This clinical trial update presents Phase 2 results for tralokinumab in adults with asthma, evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2017-03-06